β-lactamases in ampicillin-resistant Escherichia coli isolates from foods, humans, and healthy animals

Antimicrobial Agents and Chemotherapy

Volumn 46, Issue 10, 2002, Pages 3156-3163

  Briñas, Laura ^a   Zarazaga, Myriam ^a   Sáenz, Yolanda ^a   Ruiz Larrea, Fernanda ^a   Torres, Carmen ^a  

^a UNIVERSITY OF LA RIOJA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; AZTREONAM; BETA LACTAMASE; CEFAZOLIN; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; IMIPENEM; TICARCILLIN;

AMINO ACID SEQUENCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; ENZYME ANALYSIS; ESCHERICHIA COLI; GENE MUTATION; HUMAN; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PENICILLIN RESISTANCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; SEQUENCE ANALYSIS;

AMPICILLIN; ANIMALS; ANIMALS, DOMESTIC; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; BETA-LACTAMS; CATTLE; CHICKENS; DOGS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FECES; HUMANS; MEAT PRODUCTS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; SWINE;

EID: 0036784040     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.46.10.3156-3163.2002     Document Type: Article

References (52)

1. A standard numbering scheme for the class A β-lactamases
2. A novel class C β-lactamase (FOX-2) in Escherichia coli conferring resistance to cephamycins
3. Nucleotide sequences of the genes coding for the TEM-like β-lactamases IRT-1 and IRT-2 (formerly called TRI-1 and TRI-2)
4. Inhibitor resistant class A beta-lactamases
5. Molecular characterization of FOX-4, a new AmpC-type plasmid-mediated β-lactamase from an Escherichia coli strain isolated in Spain
6. Characterization of extended-spectrum cephalosporin resistance in E. coli isolates associated with bovine calf diarrhoeal disease
7. Inhibitor-resistant TEM (IRT) β-lactamases with different substitutions at position 244
8. Epidemiology of plasmid-mediated beta-lactamases in enterobacteria Swedish neonatal wards and relation to antimicrobial therapy
9. A functional classification scheme for beta-lactamases and its correlation with molecular structures
10. Nomenclature of TEM β-lactamases
11. Mutations in the ampC promoter of Escherichia coli isolates resistant to oxyiminocephalosporins without extended spectrum β-lactamase production
12. Analysis of the effects of -42 and -32 ampC promoter in clinical isolates of Escherichia coli hyperproducing AmpC
13. Inhibitor resistant TEM. β-lactamases: Phenotypic, genetic and biochemical characteristics
14. Two improved promoter sequences for the beta-lactamase expression arising from a single base-pair substitution
15. Variations between the nucleotide sequences of Tn1, Tn2, and Tn3 and expression of beta-lactamase in Pseudomonas aeruginosa and Escherichia coli
16. Isolation and characterization of DNA repetitions carrying the chromosomal β-lactamase gene of Escherichia coli K12
17. Patterns and mechanisms of resistance to β-lactams and β-lactamase inhibitors in uropathogenic Escherichia coli isolates from dogs in Portugal
18. Transferable class C β-lactamases in Escherichia coli strains isolated in Greek hospitals and characterization of two enzyme variants (LAT-3 and LAT-4) closely related to Citrobacter freundii AmpC β-lactamase
19. Gene sequence and biochemical characterization of FOX-1 from Klebsiella pneumoniae, a new AmpC-type plasmid-mediated β-lactamase with two molecular variants
20. Sequence of the genes blaT-1B and blaT-2
21. Updated sequence information for TEM β-lactamase genes
22. Beta-lactamase patterns and betalactam/clavulanic acid resistance in Escherichia coli isolated from fecal samples from healthy volunteers
23. Plasmid encoded β-lactamases resistant to inhibition by clavulanic acid produced by calf faecal coliforms
24. AmpC cephalosporinase of Escherichia coli K-12 has a different evolutionary origin from that of β-lactamases of the penicillinase type
25. The E. coli β-lactamase attenuator mediates growth-dependent regulation
26. Sequence elements determining ampC promoter strength in E. coli
27. Extended-spectrum and inhibitor-resistant TEM-type β-lactamases: Mutations, specificity, and three-dimensional structure
28. TEM genes and their promoters
29. TEM genes
30. β-Lactamases in laboratory and clinical resistance
31. Beta-lactamase-mediated resistance and opportunities for its control
32. Characterization of FOX-3, an AmpC-type plasmid-mediated β-lactamase from an Italian isolate of Klebsiella oxytoca
33. Activities of imipenem and cephalosporins against clonally related strains of Escherichia coli hyperproducing chromosomal β-lactamases and showing altered porin profiles
34. OXA-type β-lactamases
35. Molecular basis of AmpC hyperproduction in clinical isolates of Escherichia coli
36. Identification of a novel AmpC beta-lactamase promoter in a clinical isolate of Escherichia coli
37. AmpC beta-lactamase hyperproduction in Escherichia coli: Natural ampicillin resistance generated by horizontal chromosomal DNA transfer from Shigella
38. β-Lactamases responsible for resistance to expanded-spectrum cephalosporins in Klebsiella pneumoniae Escherichia coli, and Proteus mirabilis isolates recovered in South Africa
39. Cloning and biochemical characterization of FOX-5, an AmpC-type plasmid-encoded β-lactamase from a New York City Klebsiella pneumoniae clinical isolate
40. Antibiotic resistance in Escherichia coli isolates obtained from animals, foods and humans in Spain
41. Beta-lactam resistance in normal faecal flora from South Africa
42. A secondary drug resistance mutation of TEM-1 β-lactamases that suppresses misfolding and aggregation
43. Incidence and mechanisms of resistance to the combination of amoxicillin and clavulanic acid in Escherichia coli
44. Characterization of clinical isolates of Klebsiella pneumoniae from 19 laboratories using the National Committee for Clinical Laboratory Standards extended-spectrum β-lactamase detection methods
45. Characterization of integrons in Escherichia coli of the normal intestinal flora of swine
46. Nucleotide sequence of the ampicillin resistance gene of Escherichia coli plasmid pBR322
47. Selection and characterization of β-lactam-β-lactamase inactivator-resistant mutants following PCR mutagenesis of the TEM-1 β-lactamase gene
48. Activity of beta-lactamase inhibitor combinations on Escherichia coli isolates exhibiting various patterns of resistance to betalactam agents
49. Clinical isolates of Escherichia coli producing TRI β-lactamases: Novel TEM-enzymes conferring resistance to β-lactamase inhibitors
50. Evidence for transfer of CMY-2 AmpC β-lactamase plasmids between Escherichia coli and Salmonella isolates from food animals and humans
51. Emergence of clinical isolates of Escherichia coli producing TEM-1 derivatives or an OXA-1 β-lactamase conferring resistance to β-lactamase inhibitors